GK8-12520-09232
2 vaccinations
2 coded responses
2 check-ins
2 free-text entries
2 call cases
- Sex
- Male
- Age at first dose
- 05-11
- ZIP prefix
- 974 / OR
- Registered
- 2022-01-28
- Relationship
- Child or adolescent in my care
- Guardian
- ZM2-26318-93284
- Race
- Multiracial
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-11-19
Dose 1 — Pfizer-BioNTech
-
2021-12-10
Dose 2 — Pfizer-BioNTech
-
2022-01-28
Registered in v-safe
-
2022-03-11
Survey response — 3 months, dose 2, dependentMedDRA: COVID-19, Headache, Office visit, Vomiting — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Symptoms: COVID 19, vomiting and headaches · Healthcare visit (other): Dr visitMedDRA releases: 2024-11 · check-in free text available
-
2022-03-11
Report sent to call center — 3 months, dose 2, dependentBe unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prOutpatient clinic or urgent care clinic visit · 1 call case(s)
-
2022-03-14
Call successfulDoes not wish to fill out VAERS report
-
2022-06-10
Survey response — 6 months, dose 2, dependentMedDRA: Gastrointestinal disorder, Nasopharyngitis, Pre-existing disease — Feeling: Fair · Be unable to do their normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Colds, allergies, stomache issuesMedDRA releases: 2024-11 · check-in free text available
-
2022-06-10
Report sent to call center — 6 months, dose 2, dependentBe unable to do their normal daily activities · Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2022-06-13
-
2022-06-14
Call successfulParticipant prefers to complete VAERS report online
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-11-19 | Pfizer-BioNTech | No |
| 2 | 2021-12-10 | Pfizer-BioNTech | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2022-03-11 | Successful 2022-03-14 |
Does not wish to fill out VAERS report |
| 2022-06-10 | Successful 2022-06-14 |
Participant prefers to complete VAERS report online |
Free text
Release 11 — 3 months, dose 2, dependent
Release 12 — 6 months, dose 2, dependent
Symptoms: Colds, allergies, stomache issues
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Office visit | · | · | ✓ |
| SD | COVID-19 | · | · | ✓ |
| SD | Gastrointestinal disorder | · | · | ✓ |
| SD | Headache | · | · | ✓ |
| SD | Nasopharyngitis | · | · | ✓ |
| SD | Pre-existing disease | · | · | ✓ |
| SD | Vomiting | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release